• Investors
    • Overview
    • Press Release
    • Events and Presentations
    • Financial Filings
    • Stock Information
    • Corporate Governance
    • Contact
  • Newsroom
    • Top News
    • Archives
    • In the News
    • Media Inquiries
  • Careers
  • Contact Us
Veradermics Logo
  • About Us
    • Overview
    • Our Team
    • Board of Directors
    • Investors
    • Business Development
  • Our Approach
  • Our Pipeline
    • Overview
    • Pattern Hair Loss
    • Other Exploratory Assets
    • About Pattern Hair Loss
    • About VDPHL01
    • Molluscum Contagiosum
    • Alopecia Areata
  • About VDPHL01
  • Clinical Trials
  • About Us
    • Overview
    • Our Team
    • Board of Directors
    • Investors
    • Business Development
  • Our Approach
  • Our Pipeline
    • Overview
    • Pattern Hair Loss
    • Other Exploratory Assets
    • About Pattern Hair Loss
    • About VDPHL01
    • Molluscum Contagiosum
    • Alopecia Areata
  • About VDPHL01
  • Clinical Trials
  • Investors
    • Overview
    • Press Release
    • Events and Presentations
    • Financial Filings
    • Stock Information
    • Corporate Governance
    • Contact
  • Newsroom
    • Top News
    • Archives
    • In the News
    • Media Inquiries
  • Careers
  • Contact Us

In the News

Gaurav Munj2025-12-10T12:49:45+00:00

Newsroom

In the News

  • Top News
  • Archives
  • In the News
  • Media Inquiries
Practical Dermatology

New Treatment Option for Androgenetic Alopecia

New York Post Logo

New treatment for hair loss shows promise — paid volunteers needed to test it out

Hartford Business Jounral

New Haven biopharma firm Veradermics raises $75M in Series B financing round

Forbes

This Startup Raised $20.7 Million To Develop A Kid-Friendly Wart Treatment

Slate News Logo

Why Are We Still Killing Warts the Way We Did in the 1950s? Rethinking a pesky condition.

The Business Journals

Kansas City dermatologist launches startup to address common childhood ailment

Footer Shape
Media Inquiries
Veradermics Logo

470 James St., Suite 14
New Haven, CT 06513

 

+1.22.VERA.DERM
(+1.228.372.3376)

linkedin twitter Instagram
  • About Us
  • Our Approach
  • Our Pipeline
  • Clinical Trials
  • Investors
  • Newsroom
  • Careers
  • Contact Us

Veradermics is on a mission to make long-ignored dermatology and aesthetics conditions simple — replacing false hope, confusion, and questionable results with solutions that people and providers can trust.

© 2025 Veradermics, Inc. All Rights Reserved.

  • Terms of Use
  • Privacy Policy
  • Washington State Privacy